BackgroundCamelina sativa, an oilseed crop in the Brassicaceae family, has inspired renewed interest due to its potential for biofuels applications. Little is understood of the nature of the C. sativa genome, however. A study was undertaken to characterize two genes in the fatty acid biosynthesis pathway, fatty acid desaturase (FAD) 2 and fatty acid elongase (FAE) 1, which revealed unexpected complexity in the C. sativa genome.ResultsIn C. sativa, Southern analysis indicates the presence of three copies of both FAD2 and FAE1 as well as LFY, a known single copy gene in other species. All three copies of both CsFAD2 and CsFAE1 are expressed in developing seeds, and sequence alignments show that previously described conserved sites are present, suggesting that all three copies of both genes could be functional. The regions downstream of CsFAD2 and upstream of CsFAE1 demonstrate co-linearity with the Arabidopsis genome. In addition, three expressed haplotypes were observed for six predicted single-copy genes in 454 sequencing analysis and results from flow cytometry indicate that the DNA content of C. sativa is approximately three-fold that of diploid Camelina relatives. Phylogenetic analyses further support a history of duplication and indicate that C. sativa and C. microcarpa might share a parental genome.ConclusionsThere is compelling evidence for triplication of the C. sativa genome, including a larger chromosome number and three-fold larger measured genome size than other Camelina relatives, three isolated copies of FAD2, FAE1, and the KCS17-FAE1 intergenic region, and three expressed haplotypes observed for six predicted single-copy genes. Based on these results, we propose that C. sativa be considered an allohexaploid. The characterization of fatty acid synthesis pathway genes will allow for the future manipulation of oil composition of this emerging biofuel crop; however, targeted manipulations of oil composition and general development of C. sativa should consider and, when possible take advantage of, the implications of polyploidy.
is an open access repository that collects the work of Arts et Métiers ParisTech researchers and makes it freely available over the web where possible.
AbstractThis paper presents a 2-D real-time modeling approach for a proton-exchange-membrane fuel cell (PEMFC). The proposed model covers multi-physical domains for both fluidic and electrochemical features, which considers in particular the flow field geometric form of fuel cell. The characteristics of reactant gas convection in the serpentine gas pipeline and diffusion phenomenon through the gas diffusion layer (GDL) are thoroughly considered in fluidic domain model. In addition, a three levels iterative solver is developed in order to accurately calculate the implicit spatial physical quantities distribution in electrochemical domain. Moreover, the proposed 2-D real-time modeling approach uses a numerical method to achieve a fast execution time, and can thus be further easily applied to any realtime control implementation or online diagnostic system. After experimental validation under different fuel cell operating conditions, an iterative Least Angle Regression (LAR) method is used to efficiently and accurately perform the global parameters sensitivity analysis based on Sobol definition. The online analysis results give an insight into the influences of modeling parameters on fuel cell performance.The effect of interactions between parameters' sensitivities is especially investigated, which can provide useful information for degradation understanding, parameters tuning, re-calibration of the parameters and online prognostic.Keywords: Proton exchange membrane fuel cell, flow field geometric form, global parameters sensitivity, effect of interactions.
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.